Facebook
Toll-free:1-888-852-8623

All categories

  • All categories
  • Flow Cytometry Antibodies
  • Immunoassays
  • Antibodies and Reagents
  • Apoptosis and Cell Health Detection
  • Metabolism Assays
  • Cell Isolation Products
  • Cell Identification Kits
  • Proteins and Peptides
  • Cell Culture
Please enter the item number/product keyword!
Keyword cannot be empty !
INSERT SYMBOLS:
  • α
  • β
  • γ
  • δ
  • ε
  • ζ
  • η
  • θ
  • κ
  • μ
  • ω
  • σ
  • τ
  • λ
  • ⅩⅢ
  • ⅩⅢ
  • ⅩⅣ
  • ⅩⅤ
  • ⅩⅦ
  • ⅩⅧ
  • UP ↑
AF/LE Purified Anti-Human IL-6 Antibody[MQ2-13A5] - 1
  • AF/LE Purified Anti-Human IL-6 Antibody[MQ2-13A5] - 1
All Size Price Qty
100μg $ 50.00
- +
25μg $ 20.00
- +
100mg $ 4100.00
- +
50mg $ 2850.00
- +
25mg $ 1900.00
- +
5mg $ 570.00
- +
1mg $ 156.00
- +
Add to cart

For research use only.

Conjugation: None (AF/LE)

APC Elab Fluor®700 FITC None (AF/LE) PE Unconjugated Show More

Inquire about other conjugation options

Verified Samples Verified Samples in FCM: HEK293T cells transfected with pcDNA3.1 plasmid encoding Human IL-6 gene
Dilution FCM 2 μg/mL(0.5×106-1×106 cells)
Isotype Rat IgG1, κ
Host Rat
Reactivity Human
Applications FCM
Clonality Monoclonal
Immunogen Recombinant Human IL-6 protein
Abbre IL-6
Synonyms B cell differentiation factor,  B cell stimulatory factor 2,  BSF 2,  Hepatocyte stimulatory factor,  Hybridoma growth factor Interferon beta-2,  IL 6,  Interferon beta 2,  Interleukin 6 (interferon beta 2),  Interleukin BSF 2,  Interleukin-6,  IL-6,  B-cell hybridoma growth factor,  Interleukin HP-1,  IFNB,  Interleukin HP,  Interferon Beta,  B-Cell Stimulatory Factor,  IFN-Beta,  B-cell hybridoma growth factor,  B-Cell Stimulatory Factor 2,  BSF2,  BSF-2,  CDF,  CTL Differentiation Factor,  HGF,  HSF,  Hybridoma Growth Factor,  IFN-Beta-2,  IL-6,  Interferon Beta-2,  Interleukin 6,  Interleukin HP-1,  Interleukin-6,  IL6,  IFNB2
Swissprot
Cellular Localization Secreted
Tissue Specificity Produced by skeletal muscle.
Concentration ≥ 1 mg/mL
Buffer Sterile PBS, pH 7.2. < 1.0 EU per mg of the antibody as determined by the LAL method.
Purification Method >98%, Protein A/G purified
Research Areas Immunology,  Cancer,  Metabolism,  Neuroscience,  Invasion and Metastasis,  Cytokine and Growth Factors,  Metabolic disorders,  Obesity,  Jak/STAT Signaling Pathway,  Neurodegenerative Diseases Markers,  Angiogenesis,  Angiogenic growth factors,  Tumor Immunity,  Prostate Cancer Markers,  Tumor Biomarkers
Clone MQ2-13A5
Conjugation None (AF/LE)
Storage Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
Shipping Ice bag
background Interleukin-6 (IL-6) is a pleiotropic, alpha -helical, phosphorylated and variably glycosylated cytokine that plays important roles in the acute phase reaction, inflammation, hematopoiesis, bone metabolism, and cancer progression. Mature human IL-6 is 183 amino acids (aa) in length expressed as a 22-28 kDA molecular weight protein. IL-6 shares 39% aa sequence identity with mouse and rat IL-6. Alternative splicing generates several isoforms with internal deletions, some of which exhibit antagonistic properties. IL-6 induces signaling through a cell surface heterodimeric receptor complex composed of a ligand binding subunit (IL-6 R alpha) and a signal transducing subunit (gp130). IL-6 binds to IL-6 R alpha, triggering IL-6 R alpha association with gp130 and gp130 dimerization. gp130 is also a component of the receptors for CLC, CNTF, CT-1, IL-11, IL-27, LIF, and OSM. Soluble forms of IL-6 R alpha are generated by both alternative splicing and proteolytic cleavage. In a mechanism known as trans-signaling, complexes of soluble IL-6 and IL-6 R alpha elicit responses from gp130-expressing cells that lack cell surface IL-6 R alpha. Trans-signaling enables a wider range of cell types to respond to IL-6, as the expression of gp130 is ubiquitous, while that of IL-6 R alpha is predominantly restricted to hepatocytes, monocytes, and resting lymphocytes. Soluble splice forms of gp130 block trans-signaling from IL-6/IL-6 R alpha but not from other cytokines that use gp130 as a co-receptor. IL-6, along with TNF-alpha and IL-1, function to drive the acute inflammatory response and the transition from acute inflammation to either acquired immunity or chronic inflammatory disease. When dysregulated, it contributes to chronic inflammation in obesity, insulin resistance, inflammatory bowel disease, arthritis, sepsis, and atherosclerosis. IL-6 can also function as an anti-inflammatory molecule, as in skeletal muscle where it is secreted in response to exercise. In addition, it enhances hematopoietic stem cell proliferation and the differentiation of Th17 cells, memory B cells, and plasma cells.
Cat.No. Product Name Clone No.
  • IF:{{item.impact}}

    Journal:{{item.journal}} ({{item.year}})

    DOI:{{item.doi}}

    Reactivity:{{item.species}}

    Sample Type:{{item.sample_type}}

  • Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}

No files available. Please enter the correct identification code in the search area to query the relevant documents.

empty
Product Information
Title Status Valid until Action
{{v.文件名}} {{v.status_str}} {{v.timestamp_str}} Download /

*Note:Please download the relevant files within the validity period. After expiration, file preview and download will not be available on the page.

确定